Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aadi Bioscience, Inc. (ARPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 25,569 shares
@ $4.3685, valued at
$111.7k
Sold 16,431 shares
@ $4.0961, valued at
$67.3k
|
|
| 10/03/2023 |
4
| Lennon David James (CEO) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 32,558 restricted stock units
@ $0
Granted 490,000 options to buy
@ $0 |
|
| 10/03/2023 |
3
| Lennon David James (CEO) has filed a Form 3 on Aadi Bioscience, Inc. |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 22,710 shares
@ $5.219, valued at
$118.5k
Sold 19,290 shares
@ $5.197, valued at
$100.3k
|
|
| 07/06/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 10,000 shares
@ $6.6446, valued at
$66.4k
Sold 16,171 shares
@ $6.5471, valued at
$105.9k
Sold 15,829 shares
@ $6.2716, valued at
$99.3k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/06/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 7,260 shares
@ $8.1891, valued at
$59.5k
|
|
| 06/05/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 4,982 shares
@ $7.9222, valued at
$39.5k
Sold 12,443 shares
@ $7.9901, valued at
$99.4k
Sold 17,315 shares
@ $8.1096, valued at
$140.4k
|
|
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 24,479 shares
@ $7.7983, valued at
$190.9k
Sold 7,521 shares
@ $7.4757, valued at
$56.2k
Sold 7,695 shares
@ $7.6768, valued at
$59.1k
|
|
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/05/2023 |
4
| Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Sold 9,583 shares
@ $7.446, valued at
$71.4k
Sold 12,869 shares
@ $7.3029, valued at
$94k
Sold 7,336 shares
@ $7.235, valued at
$53.1k
|
|
| 04/04/2023 |
4
| Giacobello Scott M. (CFO, Interim CEO & President) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 100,000 options to buy
@ $7.47, valued at
$747k
|
|
| 04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/28/2023 |
8-K/A
| Quarterly results |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/02/2023 |
4
| ITRI LORETTTA M (Chief Medical Officer) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 102,350 options to buy
@ $10.93, valued at
$1.1M
|
|
| 03/02/2023 |
4
| Giacobello Scott M. (CFO) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 90,000 options to buy
@ $10.93, valued at
$983.7k
|
|
| 03/02/2023 |
4
| Delaney Brendan (See remarks) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 235,000 options to buy
@ $10.93, valued at
$2.6M
|
|
| 02/10/2023 |
SC 13G/A
| Satter Muneer A reports a 6.7% stake in Aadi Bioscience, Inc. |
| 01/23/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 01/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|
|